Long-term outcome of very early cyclosporine minimization and de novo everolimus therapy in kidney transplant recipients: a pharmacokinetic guided approach.

Sumethkul, V; Tankee, P; Chalermsanyakorn, P; Jirasiritham, S

Sumethkul, V; Tankee, P; Chalermsanyakorn, P; Jirasiritham, S.

Affiliation

Sumethkul V; Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ravsm@mahidol.ac.th

Transplant Proc ; 42(10): 4040-2, 2010 Dec.

Article in En | MEDLINE | ID: mdl-21168621

Subject(s)

Cyclosporine/administration & dosage; Immunosuppressive Agents/administration & dosage; Kidney Transplantation; Sirolimus/analogs & derivatives; Treatment Outcome; Area Under Curve; Creatinine/blood; Cyclosporine/pharmacokinetics; Dose-Response Relationship, Drug; Everolimus; Glomerular Filtration Rate; Humans; Immunosuppressive Agents/pharmacokinetics; Sirolimus/administration & dosage; Sirolimus/pharmacokinetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Treatment Outcome / Cyclosporine / Sirolimus / Immunosuppressive Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google